Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age
J Infect Dis
.
2021 Feb 3;223(2):353.
doi: 10.1093/infdis/jiaa560.
Authors
Roman Chlibek
1
,
José M Bayas
2
,
Harry Collins
3
,
Maria Luisa Rodriguez de la Pinta
4
,
Edouard Ledent
5
,
Johann F Mols
5
,
Thomas C Heineman
6
Affiliations
1
Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
2
Centro de Vacunación de Adultos, Servicio de Medicina Preventiva y Epidemiología, Hospital Clínic, Barcelona, Spain.
3
Anderson & Collins Clinical Research, Inc, Edison, New Jersey.
4
Occupational Risk Prevention Department, Puerta de Hierro Hospital, Madrid, Spain.
5
GlaxoSmithKline Vaccines, Rixensart, Belgium.
6
GlaxoSmithKline Vaccines, King of Prussia, Pennsylvania.
PMID:
33215671
DOI:
10.1093/infdis/jiaa560
No abstract available
Publication types
Published Erratum